Cargando…

Novel Cancer Immunotherapies and Antitumor Immunity

Detalles Bibliográficos
Autores principales: Zhao, Lei, Zhang, Jianjun, Xu, Liang, Abbas, Hussein A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679854/
https://www.ncbi.nlm.nih.gov/pubmed/31428655
http://dx.doi.org/10.1155/2019/3742061
_version_ 1783441401996902400
author Zhao, Lei
Zhang, Jianjun
Xu, Liang
Abbas, Hussein A.
author_facet Zhao, Lei
Zhang, Jianjun
Xu, Liang
Abbas, Hussein A.
author_sort Zhao, Lei
collection PubMed
description
format Online
Article
Text
id pubmed-6679854
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-66798542019-08-19 Novel Cancer Immunotherapies and Antitumor Immunity Zhao, Lei Zhang, Jianjun Xu, Liang Abbas, Hussein A. J Immunol Res Editorial Hindawi 2019-07-22 /pmc/articles/PMC6679854/ /pubmed/31428655 http://dx.doi.org/10.1155/2019/3742061 Text en Copyright © 2019 Lei Zhao et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Zhao, Lei
Zhang, Jianjun
Xu, Liang
Abbas, Hussein A.
Novel Cancer Immunotherapies and Antitumor Immunity
title Novel Cancer Immunotherapies and Antitumor Immunity
title_full Novel Cancer Immunotherapies and Antitumor Immunity
title_fullStr Novel Cancer Immunotherapies and Antitumor Immunity
title_full_unstemmed Novel Cancer Immunotherapies and Antitumor Immunity
title_short Novel Cancer Immunotherapies and Antitumor Immunity
title_sort novel cancer immunotherapies and antitumor immunity
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679854/
https://www.ncbi.nlm.nih.gov/pubmed/31428655
http://dx.doi.org/10.1155/2019/3742061
work_keys_str_mv AT zhaolei novelcancerimmunotherapiesandantitumorimmunity
AT zhangjianjun novelcancerimmunotherapiesandantitumorimmunity
AT xuliang novelcancerimmunotherapiesandantitumorimmunity
AT abbashusseina novelcancerimmunotherapiesandantitumorimmunity